APA (7th ed.) Citation

Catar, R. A., Bartosova, M., Kawka, E., Chen, L., Marinovic, I., Zhang, C., . . . Witowski, J. (2022). Angiogenic role of mesothelium-derived chemokine CXCL1 during unfavorable peritoneal tissue remodeling in patients receiving peritoneal dialysis as renal replacement therapy. Frontiers in immunology, 13, .

Chicago Style (17th ed.) Citation

Catar, Rusan Ali, et al. "Angiogenic Role of Mesothelium-derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy." Frontiers in Immunology 13 (2022).

MLA (9th ed.) Citation

Catar, Rusan Ali, et al. "Angiogenic Role of Mesothelium-derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy." Frontiers in Immunology, vol. 13, 2022.